2025-04-04 - Analysis Report
## Merck & Co Inc (MRK) Stock Analysis

**0. Key Figures:**

* **Cumulative Return (MRK):** 33.55%
* **Cumulative Return (VOO):** 85.44%
* **Return Difference:** -51.9%
* **Relative Divergence:** 22.0% (Indicates MRK's performance is in the 22nd percentile relative to its historical performance compared to VOO)
* **Current Price:** $86.39
* **5-Day Moving Average:** $87.82
* **20-Day Moving Average:** $91.44
* **60-Day Moving Average:** $92.12
* **RSI:** 26.45 (Suggests oversold conditions)
* **PPO:** -0.759 (Indicates bearish momentum)
* **Market Risk Indicator (MRI):** 0.432 (Low to Medium Risk)
* **Expected Return (vs. S&P 500):** 11.8% (Long-term, 2+ years)


**1. Company Overview and Performance Comparison:**

Merck & Co Inc is a leading global healthcare company.  The provided data shows MRK significantly underperformed the S&P 500 (VOO) over the analyzed period, with a -51.9% difference in cumulative returns.  The relative divergence of 22% suggests that while underperforming, this level of underperformance is not exceptionally rare based on historical data compared to the S&P 500.

**Alpha and Beta Analysis:**

The provided data shows varying alpha and beta values across different time periods.  Alpha, generally, indicates outperformance relative to the market (positive alpha is good), while beta measures the volatility relative to the market (higher beta indicates higher volatility). The data suggests periods of both outperformance and underperformance relative to the market, with considerable volatility.  The significant negative alpha in 2019-2021 and 2023-2025 periods requires further investigation. Market capitalization (Cap(B)) shows growth trends.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 2.0% | 14.0% | -16.0% | 109.0 |
| 2016-2018  | 43.0% | 14.0% | 36.0% | 152.5 |
| 2017-2019  | 44.0% | 14.0% | 25.0% | 186.5 |
| 2018-2020  | 25.0% | 10.4% | -9.0% | 173.1 |
| 2019-2021  | -2.0% | 14.2% | -75.0% | 176.1 |
| 2020-2022  | 31.0% | 45.4% | 20.0% | 263.1 |
| 2021-2023  | 45.0% | 45.4% | 27.0% | 265.8 |
| 2022-2024  | 14.0% | 45.4% | -9.0% | 249.1 |
| 2023-2025  | -36.0% | 50.6% | -72.0% | 218.2 |


**2. Recent Price Movement:**

MRK's current price is below its 5, 20, and 60-day moving averages, suggesting a bearish trend.  The recent price change of -$0.24 reflects a minor decline.


**3. Technical Indicators and Expected Return:**

The RSI of 26.45 indicates the stock is oversold, potentially suggesting a bounce. However, the negative PPO (-0.759) confirms bearish momentum.  The recent relative divergence increase of 5.0 suggests short-term upward movement, but this is contradicted by longer-term indicators.  The 11.8% expected return is a positive indicator for long-term investors, though it needs to be considered in context of the current market conditions and the relatively low recent performance compared to the S&P 500.  The MRI of 0.432 indicates low to medium risk.


**4. Recent Earnings Analysis:**

The earnings data shows some volatility in EPS and revenue.  Further analysis is needed to determine the underlying reasons for this fluctuation.  A more detailed breakdown of quarterly performance and explanations for these variations would be beneficial.


| 날짜 | EPS | 매출 |
|---|---|---|
| 2024-11-06 | 1.25 | 16.66 B$ |
| 2024-08-05 | 2.15 | 16.11 B$ |
| 2024-05-03 | 1.88 | 15.78 B$ |
| 2023-11-03 | 1.87 | 15.96 B$ |
| 2024-11-06 | 1.87 | 15.96 B$ |


**5. Financial Information:**

The financial data reveals consistent high profit margins, however, Revenue shows some variability.  ROE (Return on Equity) also fluctuates, with a negative value in 2023-12-31 requiring further investigation to determine the cause.  Further analysis of these metrics, along with debt levels and cash flow, would be beneficial for a complete financial assessment.


Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $15.62B | 75.50% |
| 2024-09-30 | $16.66B | 75.51% |
| 2024-06-30 | $16.11B | 76.76% |
| 2024-03-31 | $15.78B | 77.56% |
| 2023-12-31 | $14.63B | 73.26% |


Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $46.31B | 8.08% |
| 2024-09-30 | $44.50B | 7.09% |
| 2024-06-30 | $43.58B | 12.52% |
| 2024-03-31 | $40.36B | 11.80% |
| 2023-12-31 | $37.58B | -3.26% |


**6. Overall Analysis:**

MRK's performance has lagged behind the S&P 500 over the analyzed period. While the company shows strong profitability margins,  recent price action and technical indicators point towards a bearish trend.  The long-term expected return is positive relative to the S&P 500, but further investigation is needed into the reasons for the recent underperformance, volatility in earnings, and the negative ROE in Q4 2023.  A thorough analysis of the company's financials, future pipeline, and competitive landscape is crucial for a comprehensive investment decision.  Considering the conflicting signals, a cautious approach is warranted.  More detailed financial statements and industry comparisons would strengthen this analysis significantly.
